Add this topic to your myFT Digest for news straight to your inbox
The tobacco company can justifiably claim expertise in developing alternative products that smokers will actually try
Cigarette maker secures majority of shares in UK-based medical device manufacturer
Shareholders in UK inhaler maker will have final say in a takeover battle that has divided opinion
We must allow companies to reinvent themselves and address the problems they helped create
Short-term rental provider reports strong revenue growth, but warns on spread of Covid variants
Inhaler maker draws criticism from health charity for ‘absurd’ deal
Forecasts show the rapid pace of US consumer price increases is expected to cool
Private equity group says lower offer for UK inhaler maker is final, calling off five-day auction
UK inhaler group has bungled handling competing interests from cigarette-maker Philip Morris and Carlyle
UK regulator to oversee five days of bidding for Vectura by cigarette producer and private equity firm
Tobacco group lifts bid above £1bn in battle with Carlyle as private equity targets British businesses
Group welcomes bid that threatens to scupper rival deal with Philip Morris International
Philip Morris International’s deal to buy inhaler company Vectura creates confusion on both sides
A danger for the tobacco group is expanding wholesale into industries where similarities with its core business are only superficial
Tobacco giant gatecrashes agreement with Carlyle in quest to become ‘healthcare and wellness’ group
Ramsay Health Care swoops for Spire as private equity’s Carlyle snaps up London-listed Vectura
Mike Coupe needs to stress how competitive and unprofitable supermarkets can be
UK stocks follow global rally in response to France’s presidential contest
Vectura and Skyepharma £441m merger will bolster midsized pharmaceuticals groups
Share placement shows renewed appetite in sector where Shire’s success has been the exception
Vectura, Sirius Minerals, Petroceltic, and WANdisco featured
International Edition